Federal contractor · public award history

AMGEN INC.

UEID92HARF1LKA9CAGE0JVZ6THOUSAND OAKS, CALIFORNIA

Parent: AMGEN INC. D92HARF1LKA9

Awards we know about
1
Typical size
$26.41M
Middle of their public awards
Dollars on those awards
$26.41M

Most of their awards we can see fall roughly between $26.41M and $26.41M.

From official USAspending contract records — not a capability rating, past-performance score, or recommendation to team or bid.

Awarding agencies

  • Department of Health and Human Services (1)

Industries & product codes

Award history

  • Department of Health and Human Services$26.41M
    Sep 4, 2025PIID 75A50119C00061NAICS 541714PSC AN73AWARDUSAspending ↗

    THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF ROMIPLOSTIM FOR TREATMENT OF HEMATOPOIETIC SUBSYNDROME-ACUTE RADIATION SYNDROME (HS-ARS) AND CHEMOTHERAPY-INDUCED THROMBOCYTOPENIA (CIT) AND A DRUG DELIVERY DEVICE FEASIBILITY PROJECT WITH AN OPTION TO

Intelligence only — not legal advice, not a past-performance evaluation, and not a recommendation to team or bid. Verify on USAspending and SAM.gov.

Related open government contracts

Industry 541714

Open SAM.gov notices in industries where this company has public awards — not exclusive work for this firm.